TAO Chunliang, XU Jianfeng. Efficacy of FOLFOX neoadjuvant chemotherapy combined with surgery in the treatment of advanced gastric cancer[J]. Journal of Clinical Medicine in Practice, 2013, (15): 129-131. DOI: 10.7619/jcmp.201315049
Citation: TAO Chunliang, XU Jianfeng. Efficacy of FOLFOX neoadjuvant chemotherapy combined with surgery in the treatment of advanced gastric cancer[J]. Journal of Clinical Medicine in Practice, 2013, (15): 129-131. DOI: 10.7619/jcmp.201315049

Efficacy of FOLFOX neoadjuvant chemotherapy combined with surgery in the treatment of advanced gastric cancer

More Information
  • Published Date: October 15, 2013
  • 张晓东, 龚振夏. FolFox4方案治疗晚期胃肠道恶性肿瘤42例的临床观察 [J]. 南通医学院学报, 2003(2):196.doi: 10.3969/j.issn.1674-7887.2003.02.043.
    李铁汉, 黄洁, 马俊峰. FOLFOX4方案用于进展期胃癌术后辅助化疗的临床观察 [J]. 临床外科杂志, 2007, (10):690.doi: 10.3969/j.issn.1005-6483.2007.10.018.
    金懋林, 陈强, 程风岐. 奥沙利铂联合亚叶酸钙和5氟尿嘧啶治疗晚期胃癌的研究 [J]. 中华肿瘤杂志, 2003(2):172.doi: 10.3760/j.issn:0253-3766.2003.02.022.
    YchouM, ConroyT, Seitz JF. An open phase Ⅰ study assessing the feasibility of the triple combination:oxaliplatin plus irinotecan plus leucovorin/5-fluorouraeil every 2 weeks in patients with advanced solid tumors [J]. Annals of Oncology, 2003(3):481.
    庞丹梅, 邓燕明, 林耀东. mFOLFOX6方案用于进展期胃癌术后辅助化疗的临床研究 [J]. 实用癌症杂志, 2007(3):269.doi: 10.3969/j.issn.1001-5930.2007.03.016.
    付明明, 王莹, 刘静毅. FOLFOX4方案治疗晚期胃癌的临床疗效 [J]. 现代肿瘤医学, 2010(7):1372.doi: 10.3969/j.issn.1672-4992.2010.07.42.
    de Vita F, Orditura M, Matano E. Aphase Ⅱ studyof biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid(FOLF-OX-4) as first-line treatment of advanced gastric cancer patients [J]. British Journal of Cancer, 2005(9):1644.
    赵林, 李孝远, 白春梅. 奥沙利铂联合氟尿嘧啶、四氢叶酸辅助治疗局部晚期胃癌 [J]. 中华医学杂志, 2008, (18):1264.doi: 10.3321/j.issn:0376-2491.2008.18.007.
    刘宏斌, 盛贤能, 韩晓鹏. 观察FOLFOX新辅助化疗方案治疗不能切除的进展期胃癌的疗效 [J]. 国际外科学杂志, 2010(3):174.doi: 10.3760/cma.j.issn.1673-4203.2010.03.011.
    孙秀娣, 牧人, 周有尚. 中国胃癌死亡率20年变化情况分析及其发展趋势预测 [J]. 中华肿瘤杂志, 2004(1):4.doi: 10.3760/j.issn:0253-3766.2004.01.002.
  • Related Articles

    [1]REN Fang, QIU Peng, YOU Jianglian, HE Qingqiang. Effects of programmed death receptor-1/programmed death receptor-ligand-1 inhibitor combined with chemotherapy on gastrointestinal function and inflammatory markers in peripheral blood of patients with advanced gastric cancer[J]. Journal of Clinical Medicine in Practice, 2025, 29(2): 14-18,23. DOI: 10.7619/jcmp.20245203
    [2]ZHENG Leizhen, LIU Xianli. Comparison in efficacy of neoadjuvant chemotherapies combined with surgery for advanced gastric cancer[J]. Journal of Clinical Medicine in Practice, 2021, 25(5): 26-29. DOI: 10.7619/jcmp.20201637
    [3]YANG Guohong, FAN Gaofei, WU Yang, LIU Yabei, HUANG Jin, FAN Pingsheng. Clinical effect of intraperitoneal perfusion of verapamil and chemotherapeutic drugs on treating patients with gastric cancer after operation[J]. Journal of Clinical Medicine in Practice, 2018, (3): 1-8. DOI: 10.7619/jcmp.201803001
    [4]WANG Yongqing, FAN Wen. Clinical comparative study of docetaxel or oxaliplatin combined with fluorouracil drugs in the treatment of advanced gastric cancer[J]. Journal of Clinical Medicine in Practice, 2017, (23): 50-52. DOI: 10.7619/jcmp.201723015
    [5]CHENG Xiaofei. Clinical research on TGOPC combined with docetaxel and platinum in treatment of patients with advanced gastric cancer[J]. Journal of Clinical Medicine in Practice, 2015, (19): 22-25. DOI: 10.7619/jcmp.201519007
    [6]GONG Zhimin, XU Ximing, ZHU Yanliang. Clinical research on raltitrexed combined with paclitaxel as second-line treatment for advanced gastric cancer[J]. Journal of Clinical Medicine in Practice, 2015, (19): 19-21,25. DOI: 10.7619/jcmp.201519006
    [7]SONG Min, LI Jia, LIU Hongyan, LI Xiaomin, BI Quiping, HAN Tao. Influence of postoperative chemotherapy combined with huangqi granule on quality of life and immune function in patients with medium and advanced gastric cancer[J]. Journal of Clinical Medicine in Practice, 2015, (16): 73-75. DOI: 10.7619/jcmp.201516023
    [8]CHEN Rui, AYIXIAMU, MA Yuhua, Ding Yuanda, FENG Shun. Separation of 5-fluorouracil, leucovorin calcium and oxaliplatin based on HPLC method[J]. Journal of Clinical Medicine in Practice, 2013, (15): 23-25,28. DOI: 10.7619/jcmp.201315008
    [9]ZHANG Xiang, YU Meixian, ZHOU Yajuan, ZHU Yingqin, ZHOU Lijun. Perioperative nursing for patients with advanced gastric cancer after neoadjuvant chemotherapy[J]. Journal of Clinical Medicine in Practice, 2013, (8): 7-9. DOI: 10.7619/jcmp.201308003
    [10]ZHOU Zhao-fei, LU Jian-wei, YIN Bi-jian, LIU De-lin, FENG Ji-feng, ZHU Liang-jun, PAN Liang-xi. Clinical Study of Chrono-chemotherapy with Oxaliplatin,5-fluorouracil and Folinicacid for Advanaed Gastrointestinal Cancer[J]. Journal of Clinical Medicine in Practice, 2007, (3): 16-18,23. DOI: 10.3969/j.issn.1672-2353.2007.03.005
  • Cited by

    Periodical cited type(2)

    1. 韦沅汛,陈锋,林宗汉,张驰,潘成镇,韦宗波. Notch信号通路与骨质疏松症及中医药防治. 中国组织工程研究. 2024(04): 587-593 .
    2. 杨浩东,谢兴文,李宁,李鼎鹏,丁聚贤,姚乾宁,刘凯. 中药调控Notch信号通路治疗骨质疏松症的研究. 中国骨质疏松杂志. 2023(02): 263-267 .

    Other cited types(3)

Catalog

    Article views (312) PDF downloads (4) Cited by(5)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return